What is the market cap of Kopran Ltd?

As of 26/10/2026, the market cap of Kopran Ltd stands at ₹1,204.30 Cr.

What is the PE and PB ratio of Kopran Ltd?

The PE and PB ratios of Kopran Ltd is 35.55 ratio and 92.67 ratio as of 26/10/2026.

What is the 52 week high and low of Kopran Ltd?

The 52 week high and low of Kopran Ltd is ₹295.83 and ₹107 as of 26/10/2026.

How can I buy Kopran Ltd share?

You can easily buy Kopran Ltd shares on the Bajaj Broking platform by opening a Demat account and verifying your KYC documents online. There are no account opening charges for a Demat account with Bajaj Broking.

What determines a company’s share price?

A company’s share price is determined by supply and demand dynamics in the stock market. Factors influencing it include the company’s financial performance, earnings growth, revenue, and profitability, as well as broader economic conditions, market sentiment, and investor perception. Other determinants include sector trends, government policies, interest rates, and global events. Positive news or growth prospects can drive demand and raise the share price, while negative developments can push it lower. Analysts’ recommendations, institutional buying or selling, and technical factors such as trading volume also influence price movements. Ultimately, the share price reflects the market’s collective view of a company’s current and future value.

What is the “last sale,” “bid,” and “ask” price of Kopran Ltd?

The “last sale” is the most recent price at which a stock, like Kopran Ltd , was traded. The “bid” price represents the highest price buyers are willing to pay, while the “ask” price is the lowest price sellers are ready to accept. The difference between the bid and ask is known as the spread. Monitoring these prices helps investors understand market sentiment and liquidity. For example, a narrow spread indicates high liquidity and active trading, while a wide spread may suggest lower activity or higher volatility. These metrics are crucial for executing timely buy or sell orders in the stock market.

How to read share price charts for Kopran Ltd?

Share price charts display the historical price movement of Kopran Ltd , helping investors analyse trends, patterns, and potential entry or exit points. Charts typically show candlestick patterns, line graphs, or bar charts, representing open, high, low, and close prices. Key indicators include moving averages, support and resistance levels, and trading volume. Candlestick patterns can reveal bullish or bearish trends, while volume confirms the strength of price movements. Investors can use charts for technical analysis to assess momentum, predict short-term fluctuations, or complement fundamental analysis for long-term decisions. Understanding trends over daily, weekly, or monthly periods helps in making informed trading and investment choices.

What is volatility, and how does it affect share price movement for Kopran Ltd?

Volatility measures the degree of price fluctuations of a stock over time. High volatility indicates that Kopran Ltd share price can experience large swings in short periods, while low volatility suggests stable prices. Factors causing volatility include market sentiment, earnings announcements, global events, economic indicators, and industry news. High volatility can create opportunities for traders to profit from rapid price changes but also increases risk for long-term investors. Understanding volatility helps investors manage risk, set stop-loss limits, and determine the appropriate investment horizon based on their risk tolerance.

KOPRAN LTD Share price

KOPRAN

Small Cap | Pharmaceuticals

₹249.2

+2.89 (+1.17%)

‌

Stock price as on 26 Oct 2026 at 15:30 PM

Kopran ltd share price today

Kopran Ltd share price is currently at ₹249.2, which is up by ₹2.89 from its previous closing. Today the stock has fluctuated between ₹240.05 and ₹251...

Kopran Ltd stock performance

Today’s low

₹240.05

Today’s high

₹251.7

₹249.2

52 week low

₹107

52 week high

₹295.83

₹249.2

Open

₹243.30

Previous close

₹246.30

Share volume

2,78,769

Total traded value (Lakh)

₹694.69

Upper circuit

₹295.55

Lower circuit

₹197.05

Kopran Ltd fundamentals

Market cap (Cr)

₹1,204.30

P/E ratio (TTM)

35.55

Book value per share

₹92.67

Beta

1.32

Return on equity

6.91%

Earnings per share (TTM)

₹6.95

Dividend yield

1.21%

Net profit/quarter (Cr)

₹6.72

Kopran Ltd financials

(Values in Cr)

Revenue

Net income

Particulars	Jun 26 (₹ value in crores)
Revenue	₹62.76
Operating expense	₹56.89
Net income	₹6.72
Net profit margin	10.7%
Earning per share	₹1.39
EBITDA	₹11.37
Effective tax rate	23.46%

Particulars	Mar 26 (₹ value in crores)
Revenue	₹118.04
Operating expense	₹93.97
Net income	₹18.74
Net profit margin	15.87%
Earning per share	₹3.88
EBITDA	₹27.58
Effective tax rate	25.24%

Particulars	Dec 25 (₹ value in crores)
Revenue	₹93.88
Operating expense	₹78.61
Net income	₹12.13
Net profit margin	12.92%
Earning per share	₹2.51
EBITDA	₹17.99
Effective tax rate	22.14%

Particulars	Sep 25 (₹ value in crores)
Revenue	₹42.39
Operating expense	₹47.58
Net income	-₹3.99
Net profit margin	-9.41%
Earning per share	-₹0.83
EBITDA	-₹2.88
Effective tax rate	18.06%

Particulars	Jun 25 (₹ value in crores)
Revenue	₹51.33
Operating expense	₹48.51
Net income	₹3.52
Net profit margin	6.85%
Earning per share	₹0.73
EBITDA	₹6.87
Effective tax rate	23.64%

Particulars	Mar 26 (₹ value in crores)
Revenue	₹305.65
Operating expense	₹267.25
Net income	₹30.40
Net profit margin	9.94%
Earning per share	₹6.30
EBITDA	₹49.57
Effective tax rate	24.73%

Particulars	Mar 25 (₹ value in crores)
Revenue	₹271.01
Operating expense	₹241.12
Net income	₹26.86
Net profit margin	9.91%
Earning per share	₹5.57
EBITDA	₹44.56
Effective tax rate	24.97%

Particulars	Mar 24 (₹ value in crores)
Revenue	₹337.46
Operating expense	₹309.65
Net income	₹34.64
Net profit margin	10.26%
Earning per share	₹7.18
EBITDA	₹53.64
Effective tax rate	22.19%

Particulars	Mar 23 (₹ value in crores)
Revenue	₹273.09
Operating expense	₹252.26
Net income	₹31.25
Net profit margin	11.44%
Earning per share	₹6.48
EBITDA	₹44.00
Effective tax rate	15.33%

Particulars	Mar 22 (₹ value in crores)
Revenue	₹204.52
Operating expense	₹196.38
Net income	₹11.74
Net profit margin	5.74%
Earning per share	₹2.65
EBITDA	₹23.43
Effective tax rate	27.35%

Particulars (annual)	Mar 26 (₹ value in crores)
Book value per share	₹109.82
Return on Equity (ROE)	4.91%
Return on Capital Employed (ROCE)	6.55%
Total debt to equity ratio	0.29
EBITDA margin	9.14%

Particulars (annual)	Mar 25 (₹ value in crores)
Book value per share	₹107.35
Return on Equity (ROE)	7.64%
Return on Capital Employed (ROCE)	9.6%
Total debt to equity ratio	0.24
EBITDA margin	12.21%

Particulars (annual)	Mar 24 (₹ value in crores)
Book value per share	₹101.90
Return on Equity (ROE)	10.95%
Return on Capital Employed (ROCE)	13.57%
Total debt to equity ratio	0.19
EBITDA margin	14.48%

Particulars (annual)	Mar 23 (₹ value in crores)
Book value per share	₹91.11
Return on Equity (ROE)	6.29%
Return on Capital Employed (ROCE)	8.17%
Total debt to equity ratio	0.17
EBITDA margin	9.96%

Particulars (annual)	Mar 22 (₹ value in crores)
Book value per share	₹88.40
Return on Equity (ROE)	18.19%
Return on Capital Employed (ROCE)	21%
Total debt to equity ratio	0.21
EBITDA margin	20.52%

Particulars (annual)	Mar 26 (₹ value in crores)
Book value per share	₹92.75
Return on Equity (ROE)	6.91%
Return on Capital Employed (ROCE)	9.1%
Total debt to equity ratio	0.1
EBITDA margin	16.22%

Particulars (annual)	Mar 25 (₹ value in crores)
Book value per share	₹89.35
Return on Equity (ROE)	6.33%
Return on Capital Employed (ROCE)	8.54%
Total debt to equity ratio	0.08
EBITDA margin	16.44%

Particulars (annual)	Mar 24 (₹ value in crores)
Book value per share	₹86.47
Return on Equity (ROE)	8.53%
Return on Capital Employed (ROCE)	11.24%
Total debt to equity ratio	0.06
EBITDA margin	15.9%

Particulars (annual)	Mar 23 (₹ value in crores)
Book value per share	₹82.05
Return on Equity (ROE)	8.07%
Return on Capital Employed (ROCE)	9.34%
Total debt to equity ratio	0.08
EBITDA margin	16.11%

Particulars (annual)	Mar 22 (₹ value in crores)
Book value per share	₹78.56
Return on Equity (ROE)	3.75%
Return on Capital Employed (ROCE)	5.57%
Total debt to equity ratio	0.08
EBITDA margin	11.46%

Particulars	Mar 26 (₹ value in crores)
Cash and short term investments	₹7.22
Total assets	₹908.36
Total liabilities	₹908.36
Total equity	₹530.28
Shares outstanding	₹4.82
Price to book ratio	₹1.16
Return on assets (%)	2.83%
Return on capital	3.77%

Particulars	Mar 25 (₹ value in crores)
Cash and short term investments	₹25.86
Total assets	₹844.01
Total liabilities	₹844.01
Total equity	₹518.34
Shares outstanding	₹4.82
Price to book ratio	₹1.96
Return on assets (%)	4.56%
Return on capital	5.79%

Particulars	Mar 24 (₹ value in crores)
Cash and short term investments	₹14.19
Total assets	₹743.24
Total liabilities	₹743.24
Total equity	₹491.24
Shares outstanding	₹4.82
Price to book ratio	₹2.99
Return on assets (%)	6.85%
Return on capital	8.63%

Particulars	Mar 23 (₹ value in crores)
Cash and short term investments	₹12.57
Total assets	₹649.69
Total liabilities	₹649.69
Total equity	₹439.24
Shares outstanding	₹4.82
Price to book ratio	₹1.35
Return on assets (%)	4.19%
Return on capital	5.29%

Particulars	Mar 22 (₹ value in crores)
Cash and short term investments	₹57.13
Total assets	₹610.88
Total liabilities	₹610.88
Total equity	₹426.16
Shares outstanding	₹4.82
Price to book ratio	₹3.58
Return on assets (%)	9.99%
Return on capital	12.19%

Particulars	Mar 26 (₹ value in crores)
Cash and short term investments	₹2.17
Total assets	₹605.89
Total liabilities	₹605.89
Total equity	₹447.83
Shares outstanding	₹4.82
Price to book ratio	₹1.16
Return on assets (%)	5.01%
Return on capital	6.15%

Particulars	Mar 25 (₹ value in crores)
Cash and short term investments	₹21.01
Total assets	₹546.48
Total liabilities	₹546.48
Total equity	₹431.43
Shares outstanding	₹4.82
Price to book ratio	₹1.96
Return on assets (%)	4.91%
Return on capital	5.63%

Particulars	Mar 24 (₹ value in crores)
Cash and short term investments	₹7.42
Total assets	₹510.87
Total liabilities	₹510.87
Total equity	₹416.86
Shares outstanding	₹4.82
Price to book ratio	₹2.99
Return on assets (%)	6.77%
Return on capital	7.88%

Particulars	Mar 23 (₹ value in crores)
Cash and short term investments	₹2.59
Total assets	₹505.94
Total liabilities	₹505.94
Total equity	₹395.58
Shares outstanding	₹4.82
Price to book ratio	₹1.35
Return on assets (%)	6.17%
Return on capital	7.38%

Particulars	Mar 22 (₹ value in crores)
Cash and short term investments	₹2.55
Total assets	₹464.12
Total liabilities	₹464.12
Total equity	₹378.72
Shares outstanding	₹4.82
Price to book ratio	₹3.58
Return on assets (%)	2.53%
Return on capital	2.83%

Particulars	Mar 25 (₹ value in crores)
Net income	₹51.94
Cash from operations	₹55.18
Cash from investing	-₹56.42
Cash from financing	₹25.86
Net change in cash	₹11.38
Free cash flow	₹110.09

Particulars	Mar 24 (₹ value in crores)
Net income	₹67.54
Cash from operations	₹57.58
Cash from investing	-₹43.55
Cash from financing	₹0.98
Net change in cash	₹0.69
Free cash flow	₹107.73

Particulars	Mar 23 (₹ value in crores)
Net income	₹36.06
Cash from operations	₹46.80
Cash from investing	-₹12.65
Cash from financing	-₹19.84
Net change in cash	₹1.52
Free cash flow	₹101.78

Particulars	Mar 22 (₹ value in crores)
Net income	₹81.78
Cash from operations	-₹15.20
Cash from investing	-₹84.41
Cash from financing	₹122.82
Net change in cash	₹4.93
Free cash flow	₹24.68

Particulars	Mar 21 (₹ value in crores)
Net income	₹83.33
Cash from operations	₹75.98
Cash from investing	-₹25.27
Cash from financing	-₹34.57
Net change in cash	₹0.10
Free cash flow	₹95.91

Particulars	Mar 25 (₹ value in crores)
Net income	₹35.79
Cash from operations	₹33.39
Cash from investing	-₹15.40
Cash from financing	₹5.63
Net change in cash	₹13.52
Free cash flow	₹49.93

Particulars	Mar 24 (₹ value in crores)
Net income	₹44.51
Cash from operations	₹44.79
Cash from investing	-₹6.26
Cash from financing	-₹24.08
Net change in cash	₹4.61
Free cash flow	₹54.07

Particulars	Mar 23 (₹ value in crores)
Net income	₹36.91
Cash from operations	₹23.18
Cash from investing	₹10.04
Cash from financing	-₹26.13
Net change in cash	₹0.78
Free cash flow	₹28.81

Particulars	Mar 22 (₹ value in crores)
Net income	₹16.16
Cash from operations	-₹34.19
Cash from investing	-₹100.26
Cash from financing	₹137.98
Net change in cash	-₹0.07
Free cash flow	-₹30.76

Particulars	Mar 21 (₹ value in crores)
Net income	₹32.70
Cash from operations	₹54.18
Cash from investing	-₹8.50
Cash from financing	-₹40.14
Net change in cash	₹0.11
Free cash flow	₹58.76

Company name	Price	P/E	P/B	Market cap	52 week low/high
AMBALAL SARABHAI ENTERPRISES L	₹34.60	18.6	1.67	₹265.15	₹23.12 / ₹49.98
BLISS GVS PHARMA LTD	₹628.50	48.57	5.6	₹6,686.23	₹118.35 / ₹744.75
CIPLA LTD.	₹1,337.00	30.18	3.13	₹1,08,012.30	₹1,165.55 / ₹1,672.20
FERMENTA BIOTECH LTD.	₹454.90	24.46	3.29	₹1,338.82	₹256.40 / ₹582.95

Company name	Price	P/E	P/B	Market cap	52 week low/high
AMBALAL SARABHAI ENTERPRISES L	₹34.60	18.6	1.67	₹265.15	₹23.12 / ₹49.98
BLISS GVS PHARMA LTD	₹628.50	48.57	5.6	₹6,686.23	₹118.35 / ₹744.75
CIPLA LTD.	₹1,337.00	30.18	3.13	₹1,08,012.30	₹1,165.55 / ₹1,672.20
FERMENTA BIOTECH LTD.	₹454.90	24.46	3.29	₹1,338.82	₹256.40 / ₹582.95

Kopran Ltd technical summary

₹249.2

+ 1.17 ▲

Bearish

Bullish

5 Day260.5

10 Day264.6

12 Day265.2

20 Day264.4

26 Day261.7

50 Day247.3

100 Day223.5

200 Day200.2

Investment Returns

Over 1 Month11.85%▼

Over 3 Months24.53%▲

Over 6 Months52.8%▲

Over 1 Year45.32%▲

Kopran Ltd Shareholding pattern

Public

57.26%

Promoter holdings

41.82%

FII

0.9%

DII

Promoter shares

Promoter shares	Share	Category
Oricon Enterprises Limited	62,17,183 (12.87%)	Shareholding of Promoter and Promoter Group
Panorama Finvest Pvt Ltd	38,00,000 (7.86%)	Shareholding of Promoter and Promoter Group
Sarvamangal Mercantile Co Ltd	30,72,951 (6.36%)	Shareholding of Promoter and Promoter Group
Oriental Enterprises (surendra Somani)	17,64,750 (3.65%)	Shareholding of Promoter and Promoter Group
Varun Surendra Somani	17,24,950 (3.57%)	Shareholding of Promoter and Promoter Group

About KOPRAN LTD

Kopran Limited was incorporated on April 26, 1958. The Company was promoted by the Somani group and is a group company of Parijat Enterprises. Company operates in two distinct business verticals. Company specialise in developing and manufacturing Penicillin and non-penicillin-based drugs. Leveraging cutting-edge technology, it manufactures highquality finished dosage drugs that adhere to international requirements. Kopran is one of the key contributors in the manufacturing and sale of diverse active pharmaceutical ingredients and advanced intermediates. The range of APIs manufactured by the Company includes Sterile Cephalosporins and Carbapenems. The company came out with a public issue at a premium, in Nov.'92, to finance its backward integration project to produce drug intermediates for semi-synthetic drugs, and also to expand its antibiotic facility. Kopran's bulk drug plant has been approved by the US FDA and the UK regulatory authorities. In 1995, the company was awarded the Quality Excellence award by the Indian Drug Manufacturers Association. Kopran's high growth rate in exports has been recognised by a number of awards from CHEMEXCIL and the Ministry of Commerce. The company launched new products like AZ-1 Caps, Klodip Tabs, Moclox Kid Tabs, Amyn Kid Tabs, Tini-NF, Amyn Caps and Amyn Dry Syrup. Kopran entered into a joint venture with M/s Industrial Promotion Services Ltd to take over a running unit viz Kampala Pharmaceuticals Industries Ltd in Uganda. The company has been ranked as amongst the top few fastest growing companies in India(ORG Marg-June 2000). It closed down its manufacturing facility at Saki Naka, Andheri, Bombay. Globalpharma, a joint venture with Dubai Investments Corporation started commercial production in the first quarter of 2002. The company has increased its installed capacity of Liquids by 3.00 lakhs of Litres during 2001 and consequent of this capacity expansion the total installed capacity has gone up to 12.00 lakhs of Litres. The company has also increased its installed capacity of Tablets & Capsules by 270 crores(Nos) and the total capacity has gone up to 1080 crores(Nos). In Feb. 2001, Kopran tied up with E-Merck for co-marketing a new anti-inflammatory drug, Rofecoxib, in India. Rofecoxib is one of the fast-moving non-steroid anti-inflammatory drugs (NSAID), has been launched in the international market. The Company also launched Cholestat (Atorvastatin - a cholesterol reducer) and further gave co-marketing rights for Atorvastatin to E-Merck (India). The company had launched new products in therapeutic groups like Asthma,Cardiology,Diabetes and Lifestyle products during 2003.The company has obtained approval from European Directorate for Quality of Medicines(EDQM) in September 2003. Upgradation of Formulation Manufacturing facility took place to meet with the latest International Regulatory Norms.The United Kingdom Medicines and Healthcare Products Regulatory Agency(UK MHRA) is expected to inspect the facilities in the first quarter of 2004. Kopran Pharmaceuticals Ltd., the Company marketing the SMYLE brand of products was merged into the Company effective from 1st March, 2005. The Company introduced two new bulk drugs viz. Pregabalin and Cefditorin during the year 2007. The Company during the FY 2014-15 sold the Active Pharmaceuticals Ingredients (API) business on slump sale basis to its subsidiary Kopran Research Laboratories Ltd. at a consideration of Rs 110 Crores on 30th March, 2015. Similarly, the Consumer Care Division was sold w.e.f 1 April 2015. In FY 2023, the Company filed process patent applications for Nitroxoline in India, the EU and China. It received process patent for Nitroxoline in India and registered Nitroxoline in Germany. 14 new products launched during the year 2023. The Company further undertook the expansion of the multi-product plant at the Mahad facility to manufacture new molecules in 2024. The Scheme of Amalgamation between Kopran Laboratories Limited and the Company has been approved in the Board Meeting held on March 20, 2025.

Parent Organisation

Parijat

NSE Symbol

KOPRAN

Founded

1958

KOPRAN LTD CORPORATE ACTION

Dividend date	Dividend amount	Dividend type	Record date	Instrument type
04 Sept 2025	3	Final	04 Sept 2025	Equity shares
02 Sept 2024	3	Final	03 Sept 2024	Equity shares
07 Sept 2023	3	Final	08 Sept 2023	Equity shares
04 Aug 2022	3	Final	08 Aug 2022	Equity shares
05 Aug 2021	1.5	Final	09 Aug 2021	Equity shares
05 Nov 2020	1.5	Interim	07 Nov 2020	Equity shares

View more stocks

sun pharmaceutical ind l

₹1,740

▼ 0.45%

divi s laboratories ltd

₹9,050

▲ 1.11%

torrent pharmaceuticals ltd.

₹4,550

▲ 0.56%

zydus lifesciences ltd

₹1,160.4

▲ 2.74%

laurus labs limited

₹2,058.9

▲ 4.51%

cipla ltd.

₹1,355

▲ 1.27%

dr.reddys laboratories ltd.

₹1,310.9

▲ 6.62%

What’s trending

All stocks

PERMAGN

PERMANENT MAGNETS LTD.

1028.25

+171.35 (+20%)

KREBSBIO

KREBS BIOCHEMICALS & IND

62.22

+10.37 (+20%)

VINYLINDIA

VINYL CHEMICALS (I) LTD.

240.07

+40.01 (+20%)

PERMAGN

PERMANENT MAGNETS LTD.

1037.45

+172.9 (+20%)

View all

Top gainers

DRREDDY

DR. REDDY S LABORATORIES

JSW STEEL LIMITED

BSE LIMITED

ADANI PORT & SEZ LTD

Top losers

SHRIRAMFIN

SHRIRAM FINANCE LIMITED

825

-40.00 (-4.62%)

TATACONSUM

TATA CONSUMER PRODUCT LTD

936.5

-27.40 (-2.84%)

BAJFINANCE

BAJAJ FINANCE LIMITED

HDFC LIFE INS CO LTD

Frequently asked questions

 As of 26/10/2026, at 15:30 PM, the Kopran Ltd share price stands at ₹249.2.

Related tags

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

KOPRAN LTD Share price

Kopran ltd share price today

Kopran Ltd stock performance

₹240.05

₹251.7

₹107

₹295.83

Kopran Ltd fundamentals

Kopran Ltd financials

Particulars

Jun 26 (₹ value in crores)

Revenue

₹62.76

Operating expense

₹56.89

Net income

₹6.72

Net profit margin

10.7%

Earning per share

₹1.39

EBITDA

₹11.37

Effective tax rate

23.46%

Particulars

Mar 26 (₹ value in crores)

Revenue

₹118.04

Operating expense

₹93.97

Net income

₹18.74

Net profit margin

15.87%

Earning per share

₹3.88

EBITDA

₹27.58

Effective tax rate

25.24%

Particulars

Dec 25 (₹ value in crores)

Revenue

₹93.88

Operating expense

₹78.61

Net income

₹12.13

Net profit margin

12.92%

Earning per share

₹2.51

EBITDA

₹17.99

Effective tax rate

22.14%

Particulars

Sep 25 (₹ value in crores)

Revenue

₹42.39

Operating expense

₹47.58

Net income

-₹3.99

Net profit margin

-9.41%

Earning per share

-₹0.83

EBITDA

-₹2.88

Effective tax rate

18.06%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹51.33

Operating expense

₹48.51

Net income